An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage ...

Taking aim at a longtime target of anti-vaccine activists, CDC advisors said Thursday that the U.S. should not administer ...

The 2025 Chevy Silverado EV also offers multiple drive modes to help users tailor onboard systems to the driving conditions at hand, as explained right here.

Speaking of films, we have seven live-action films in it, one of which is a reboot that was released in 2021. On top of that, there are some animated feature films too. However, we won't be talking ...

The FDA’s June 9, 2025, approval of clesrovimab (Enflonsia; Merck) to prevent respiratory syncytial virus (RSV) in infants could have potential ripple effects of RSV prevention—not only in reducing ...

Only a small percentage—10.4%—was nonfrail. Severe RSV Outcomes The researchers found that severe cases of RSV were more common among patients aged 75 to 84 years (27.4%) and 85 years and older (27.7% ...

HealthDay News — A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants. The U.S. Food and Drug Administration ...

FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59 The extension of the shot’s approval is a welcome win for company after recent setbacks Bill Sikes/AP By Helen Branswell June ...

Respiratory syncytial virus (RSV) is a leading cause of hospitalization in infants and young children, placing a significant burden on families, hospitals, and the healthcare system. Recent ...

The Food and Drug Administration (FDA) has expanded the approval of mResvia (respiratory syncytial virus [RSV] vaccine) to include active immunization in individuals 18 through 59 years of age who ...

Patients aged between 18 and 49 years more commonly had non-RSV vs RSV-related MAARI. Across all patients, those with RSV-related MAARI were more likely to have underlying coronary artery disease and ...